Several anti-influenza compounds have been described, including those that inhibit intracellular calcium, PKC, and Raf/MEK/ERK, as well as calmodulin antagonists and donors of nitric oxide (NO) [12], [14], [15], [16], [17]. This evidence concerns the gene MAPK1 and influenza.